Results 141 to 150 of about 33,599 (301)

Associations of treatment with hypnotics with suicide and attempted suicide: a nationwide cohort study [PDF]

open access: yes
Background: Hypnotics have been linked to suicidal behaviors. While existing evidence has established findings of associations, more knowledge is needed regarding benzodiazepine (BZD) and non-benzodiazepine (n-BZD) hypnotics.
Hawton, Keith   +6 more
core   +1 more source

Updated EAACI Statement on Drug Hypersensitivity Skin Testing: Methodology and Non‐Irritative Concentrations

open access: yesAllergy, EarlyView.
ABSTRACT These updated EAACI guidelines aim to standardize skin testing methodologies for both immediate and non‐immediate drug hypersensitivity reactions. For immediate reactions, the optimal testing window is 4–6 weeks post‐reaction; whereas beyond 6 months, false‐negative results increase.
Annick Barbaud   +14 more
wiley   +1 more source

A Defense of Post‐Viability Abortion

open access: yesBioethics, EarlyView.
ABSTRACT It is often thought that Thomson's Violinist argument is only applicable before the point of viability. In this paper, I propose that this is not the case, offering a novel defense of post‐viability abortion utilising Thomson's self‐defense framework. I first set out Thomson's Violinist argument and how it interacts with viability.
Jina Kim
wiley   +1 more source

Activation of peripheral NOP receptors reduces periorbital mechanical allodynia evoked by CGRP in mice

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Migraine is a neurovascular disorder largely mediated by calcitonin gene‐related peptide (CGRP). This study explores the role of the nociceptin/orphanin FQ (N/OFQ)–N/OFQ receptor (NOP) system in CGRP‐induced periorbital mechanical allodynia (PMA) in mice.
Chiara Sturaro   +14 more
wiley   +1 more source

Hypnotism [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1908
openaire   +2 more sources

Benzodiazepines and hypnotics

open access: yes, 2012
Benzodiazepines and so-called ‘Z’ drugs are used as hypnotics. Their mode of action is to enhance the activity of central γ-aminobutyric acid. Adverse effects include anterograde amnesia and paradoxical reactions.
Varma, S.
core   +1 more source

Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders

open access: yesBritish Journal of Pharmacology, EarlyView.
Chronic visceral pain imposes a major clinical challenge in gastroenterology and beyond, profoundly impacting patients' quality of life. However, limited understanding of its complex, multifaceted pathophysiology, encompassing both peripheral and central mechanisms, continues to impede the development of effective management strategies.
Fleur Veldman   +3 more
wiley   +1 more source

A Case of Successful Electroconvulsive Therapy on the Use of Sansoninto as Substitute for Benzodiazepine Hypnotics [PDF]

open access: yes
There is no information on the use of herbal medicines as substitute for benzodiazepine hypnotics in electroconvulsive therapy. A 50-year-old woman was admitted to our department due to worsening depressive symptoms. To perform electroconvulsive therapy,
Sasaki, Taro   +4 more
core   +1 more source

Pharmacological and non‐pharmacological interventions for managing sleep disorders in children with cerebral palsy: A systematic review

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
xxxxxx Aim To systematically review the effectiveness, safety, and economic evidence of pharmacological and non‐pharmacological interventions for sleep disorders in children with cerebral palsy (CP). Method Databases including MEDLINE, Embase, CENTRAL (the Cochrane Library), International Clinical Trials Registry Platform of the World Health ...
Nishant Jaiswal   +11 more
wiley   +1 more source

GLP‐1 Receptor Agonists Use in Patients With Prior Psychotropic Treatment: A Nationwide Cohort Study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Psychotropic medications are frequently associated with weight gain and metabolic syndrome. While GLP‐1 receptor agonists (GLP‐1RAs) have generated interest for managing these adverse effects, their current uses in psychiatric populations have to be described.
Nathan du Soulier   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy